The published DDI study between the respective perpetrator and victim drug was simulated and compared to observed data.

[Section 3.1](#31-Atazanavir---Raltegravir-DDI) shows concentration time profiles of raltegravir for the four clinical studies between atazanavir and raltegravir ([Iwamoto 2008](#4-References), [Krishna 2008](#4-References), [Neely 2010](#4-References), [Zhu 2010](#4-References)).

[Section 3.2](#32-Mefenamic-acid---Dapagliflozin-DDI) shows concentration time profiles of dapagliflozin of the clinical study between mefenamic acid and dapagliflozin ([Kasichayanula 2013](#4-References)).


